In a 48-year-old woman with polycystic ovary syndrome, what does a low‑normal DHEA‑S (dehydroepiandrosterone sulfate) level of 0.581 indicate and what is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

DHEA-S Level of 0.581 in a 48-Year-Old Woman with PCOS

A DHEA-S level of 0.581 (assuming units of μg/mL or 581 μg/dL) is low-normal for a 48-year-old woman with PCOS and does not indicate adrenal hyperandrogenism; this finding is expected given age-related decline in adrenal androgens and requires no specific intervention beyond standard PCOS management.

Understanding the Clinical Context

At age 48, this patient is approaching menopause, which fundamentally changes the PCOS phenotype. The Endocrine Society guidelines explicitly state that there is no consistent PCOS phenotype in postmenopausal women 1. DHEA-S naturally declines with age in all women, and this decline is particularly notable in PCOS patients over 35 years 2.

Age-Related DHEA-S Decline

  • Research demonstrates that mean DHEAS levels are markedly lower among older PCOS women (>35 years) compared to younger PCOS patients 2
  • Both DHEAS and total testosterone decrease with age in PCOS, with significant drops after age 35 (p < 0.02) 2
  • A DHEA-S of 0.581 μg/mL falls within or below the normal range for this age group, indicating no adrenal hyperandrogenism

Clinical Significance of This Finding

What This Level Tells You

This low-normal DHEA-S indicates that adrenal androgen excess is NOT a significant contributor to this patient's PCOS phenotype. Only approximately 32% of PCOS women demonstrate adrenal hyperandrogenism by DHEAS criteria 3, and your patient is clearly not in this subset.

Diagnostic Implications

The 2025 diagnostic meta-analysis confirms that DHEA-S has limited diagnostic utility compared to other androgens 4. More recent evidence from 2026 shows that:

  • Free androgen index (FAI) demonstrates the highest diagnostic value (AUC = 0.976) 5
  • DHEA-S alone explained only limited variation in other androgens 5
  • Elevated DHEA-S levels are not consistently aligned with adrenal-origin androgen dominance 5

Management Approach

No Adrenal-Specific Therapy Needed

Since DHEA-S is not elevated, there is no indication for adrenal suppression therapy. Historical data suggested that high DHEAS patients might benefit from adrenal suppression 6, but this patient does not meet those criteria.

Focus on Standard PCOS Management

Per Endocrine Society guidelines, management should address 1:

For metabolic concerns:

  • Screen for diabetes, cardiovascular disease risk factors
  • Evaluate for obstructive sleep apnea if clinically indicated
  • Consider metformin if metabolic/glycemic abnormalities are present (beneficial for metabolic parameters and menstrual irregularities)

For menstrual abnormalities:

  • Hormonal contraceptives remain first-line if still menstruating irregularly
  • Evaluate for endometrial cancer risk factors given age and likely chronic anovulation history

For hyperandrogenic symptoms (if present):

  • Hormonal contraceptives are first-line for hirsutism/acne 1
  • Note that metformin has limited or no benefit for treating hirsutism or acne 1

Important Caveats at This Age

  • Fertility is likely not a concern at age 48, so clomiphene (first-line for infertility) is irrelevant 1
  • The patient is transitioning toward menopause, where PCOS phenotype becomes inconsistent
  • Focus shifts from reproductive concerns to long-term metabolic health
  • Weight loss through lifestyle intervention remains beneficial for overall health in overweight/obese patients, though its role in improving PCOS status per se is uncertain 1

What NOT to Do

  • Do not pursue adrenal imaging or further adrenal workup based on this normal DHEA-S
  • Do not initiate adrenal suppression therapy (e.g., dexamethasone)
  • Avoid thiazolidinediones, which have an unfavorable risk-benefit ratio overall 1
  • Do not over-interpret this single androgen measurement; DHEA measurement (not DHEAS) may be more predictive of PCOS abnormalities if further androgen assessment is needed 3

References

3
Research

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2022

Related Questions

In a 40‑year‑old woman with elevated dehydroepiandrosterone sulfate (DHEA‑S) and testosterone, what is the appropriate diagnostic work‑up and initial management?
In a 31-year-old woman with polycystic ovary syndrome and elevated total testosterone (85 ng/dL) and free testosterone (4.5 pg/mL) presenting with chronic diffuse hair loss without scalp lesions, what further evaluation is recommended?
Can a young woman have Polycystic Ovary Syndrome (PCOS) with high Dehydroepiandrosterone (DHEA) and normal testosterone levels?
How to manage Polycystic Ovary Syndrome (PCOS) with elevated Dehydroepiandrosterone (DHEA) levels?
What hormonal tests should be performed in a reproductive‑age woman suspected of polycystic ovary syndrome (PCOS)?
What is the interpretation of this peripheral blood smear?
Is Vitmaon B-complex (vitamin B complex) effective for treating neuropathic pain?
What are the clinical features and appropriate empiric antibiotic regimen for Ludwig angina?
In a patient with established cardiovascular disease and diabetes who is on atorvastatin 40 mg and still has hypertriglyceridemia and elevated LDL cholesterol, should the dose be increased to 80 mg?
What is the recommended treatment regimen for Ludwig angina in pediatric patients?
What is the appropriate management for paracetamol (acetaminophen) poisoning?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.